Ep 210 [01 April 2026]: Reyna Klesh MS, Senior Director of RWD Operations at Behavioral Health Insights – We discussed Reyna's unique background and discussed generating real-world evidence (RWE) from behavioral health assessments. Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.club Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 209 [25 March 2026]: Michael Fronstin, GTM strategist, advisor and RWE industry veteran; senior advisor to many companies and founder of Vireo Strategies – We discussed Michael's unique background and discussed the practical considerations for AI in the life science arena, exploring the guardrails on use and validation. Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.club Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 208 [18 March 2026]: Mark Larkin PhD, CEO of Vitaccess – We discussed Mark's unique background and discussed the power of science-driven patient-centric approaches to Real World Evidence (RWE) and how AI-enabled dashboards are delivering real-time, real-world data (RWD) insights. Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.club Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 207 [11 March 2026]: Nicolle Gatto PhD, Chief Science Officer, Life Sciences at Datavant – We discussed Nicolle's unique background and discussed the impact of RWD on early drug development decisions and strategy. Building on her published paper (reference below), Nicolle explored how systematic use of RWD informs critical decisions in early clinical development, shaping smarter clinical & regulatory strategy from the start (& why it has been hard to adopt). Reference: Gatto NM, Campbell UB. Hope is Not a Strategy: Using Robust Real-World Evidence to Make Better Clinical Development Decisions. Ther Innov Regul Sci. 2025 Nov;59(6):1288-1293. doi: 10.1007/s43441-025-00822-x. Epub 2025 Jul 18. PMID: 40679790; PMCID: PMC12579674. > https://link.springer.com/article/10.1007/s43441-025-00822-x (https://pubmed.ncbi.nlm.nih.gov/40679790/) Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.club Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 206 [04 March 2026]: Industry luminary, Scott Ponder, CEO of Channel Mark Advisors – We discussed Scott's unique background and discussed RWD supply from the health system and data aggregator perspective, and the evolution occurring in the RWD sector. Link referenced in the discussion: https://www.linkedin.com/posts/scott-ponder-fachdm-6231515_the-real-world-data-market-a-confounding-activity-7325240643058819072-FCaG Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.club Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 205 [25 February 2026]: Matthew Gordon, Vice President Real World Evidence at Aptitude Health – We discovered Matthew's unique background and discussed how data reveals patterns—but is incomplete without the clinical voice. We explored how expert panels and clinician engagement transform RWE from analysis into meaningful, decision-ready insight. Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.club Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 204 [18 February 2026]: Keith Kallmes, President & Founder along with Kevin Kallmes, CEO and Founder of of Nested Knowledge; brother entrepreneurs – We received an update sin ce the last time they were on RWW (Ep 42 2022-02-23; Ep 101 2023-06-07) and we discussed how RWD provenance shapes life sciences: from data source traceability and quality to evolving regulatory expectations and optimized best practices in drug development research. Keith and Kevin are three-pete guests having joined us for Episode #42 on February 23, 2022 and Episode #101 on June 7, 2023. LinkedIn Post referenced during the discussion: https://www.linkedin.com/posts/stuart-mccully-80a50aa_why-rwe-became-more-acceptedand-harder-activity-7428747406197866497-2oSo Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.club Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 203 [11 February 2026]: Tom Dougherty MBA cDHSc who leads RWD Strategy for Novo Nordisk – We discussed Tom's unique background and the importance of precision in the use and deployment of RWD to support evidentiary use cases. Often referred to as "fit-for-purpose" in selection of RWD, we focused on industry stakeholders and their expectations as we progress in 2026 and beyond. "Credibility is the currency, and credibility starts with the discipline thinking!" - Tom Tom's original episode, #102 was from our podcast on June 14th, 2023. Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.club Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.